Randomized controlled trial with Reflective Respiratory Physiotherapy for Chronic Low Back Pain

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

DRKS

Registry ID

DRKS00024537

Enrollment

Registered

2021-03-16

Start date

2015-05-28

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M54.5

Interventions

Group 1: Interventiongroup: 5 sessions of Reflective Respiratory Physiotherapy of 40 minutes once a week Group 2: Waiting group, no specific therapy conducted

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: uncomplicated chronic low back pain according to the AWMF-guidelines (no indication for a specific cause/duration > 3 months) visual analogue scale pain >4.0/10 during periods of pain age 18-65 years signed consent form for participation in the study and complete questionnaires

Exclusion criteria

Exclusion criteria: indication for a specific cause of the low back pain (red flag in anamnesis or examination) indication for or existing spondyloarthropathy indication for or existing spinal stenosis spinal disc herniation diagnosed within the past three months planed or conducted spine-surgery fever acute psychiatric disease diagnosed psychogenic pain malign tumor disease addiction disease (smoking excluded) pregnancy or breastfeeding simultaneous participation in another study simultaneous participation in activating, non-pharmaceutical therapy regarding the low back pain running process due to request of early retirement

Design outcomes

Primary

Measure	Time frame
main outcome: functional disability due to back pain, measured with the Funktionsfragebogen Hannover-Rücken. Data is collected after inclusion in the study, after three sessions and after completion of intervention. Furthermore three months after completed intervention. Data of the waiting group is collected after inclusion in the study, after three, five and seventeen weeks.	—

Secondary

Measure	Time frame
secondary outcome visual analogue scale pain (0-10) of pain intensity over the past seven days visual analogue scale subjective every-day life interference (0-10) over the past seven days short form (36) health survey SF36 Intervention group: Data is collected after inclusion in the study, after three sessions and after completion of intervention. Furthermore three months after completed intervention. Waiting group: Data of the waiting group is collected after inclusion in the study, after three, five and seventeen weeks.	—

Measure

Time frame

secondary outcome visual analogue scale pain (0-10) of pain intensity over the past seven days visual analogue scale subjective every-day life interference (0-10) over the past seven days short form (36) health survey SF36 Intervention group: Data is collected after inclusion in the study, after three sessions and after completion of intervention. Furthermore three months after completed intervention. Waiting group: Data of the waiting group is collected after inclusion in the study, after three, five and seventeen weeks.

—

Countries

Germany

Contacts

Public ContactMiriam Rösner

Immanuel Krankenhaus Berlin, Standort Berlin-Wannsee Abteilung Naturheilkunde und Charité - Universitätsmedizin Berlin

miriam.roesner@immanuelalbertinen.de030 80505 682

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026